Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Dyspnea × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 7 Neoplasms 7 Colonic Neoplasms 3 Breast Neoplasms 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Cancer Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thymoma 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Surveys and Questionnaires 4 Dexamethasone 2 Calcium Dobesilate 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Sugars 1 Respiratory Therapy 1 Oxygen 1 Lisinopril 1 Fentanyl 1 Buspirone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡